SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-18-008583
Filing Date
2018-02-14
Accepted
2018-02-14 13:07:27
Documents
1
Group Members
DR. ANAND MEHRADR. JAMES I. HEALYMICHAEL F. POWELLSOFINNOVA MANAGEMENT IX, L.L.C

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv485881_sc13ga.htm SC 13G/A 73524
  Complete submission text file 0001144204-18-008583.txt   75183
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners IX, L.P. (Filed by) CIK: 0001612133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Subject) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89574 | Film No.: 18610214
SIC: 2836 Biological Products, (No Diagnostic Substances)